Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 5/20 | 0.46 |
| ▸ | GAA | P10253 | 4/20 | 0.44 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.43 |
| ▸ | CASP3 | P42574 | 1/20 | 0.43 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.43 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.43 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11443476 | 0.84 | ALDH1A1 (0.46) | ALDH1A1TSHRMAPTGAARAB9A | |
| SCHEMBL18694492 | 0.83 | ALDH1A1 (0.71) | ALDH1A1MAPTRAB9AL3MBTL1MAPK1 | |
| SCHEMBL8338087 | 0.81 | ALDH1A1 (0.69) | ALDH1A1MAPTGAARAB9AHTT | |
| SCHEMBL17629354 | 0.81 | TSHR (0.53) | ALDH1A1TSHRMAPTGAAHTT | |
| SCHEMBL18092911 | 0.80 | ALDH1A1 (0.43) | ALDH1A1TSHRMAPTGAARAB9A | |
| SCHEMBL4231163 | 0.79 | MAPT (0.59) | ALDH1A1TSHRMAPTGAAL3MBTL1 | |
| SCHEMBL17633912 | 0.79 | POLB (0.52) | ALDH1A1MAPTNPY5RMAPK1SMN1; SMN2 | |
| SCHEMBL31067434 | 0.79 | NPY5R (0.50) | ALDH1A1TSHRMAPTNPY5RHPGD | |
| SCHEMBL17064934 | 0.79 | KMT2A (0.45) | ALDH1A1MAPTGAARAB9AHTT | |
| SCHEMBL17064591 | 0.79 | NPY5R (0.50) | ALDH1A1TSHRMAPTNPY5RHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260035398-A1 | TETRADENTATE AND OCTAHEDRAL METAL COMPLEXES CONTAINING NAPHTHYRIDINOCARBAZOLE AND ITS ANALOGUES | UNIV ARIZONA STATE (US) | 2026-02-05 | — | — | US | disclosed |
| US-12426496-B2 | Organic electroluminescence device and organometallic compound for organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-09-23 | — | — | US | disclosed |
| US-12312366-B2 | Tetradentate and octahedral metal complexes containing naphthyridinocarbazole and its analogues | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2025-05-27 | — | — | US | disclosed |
| US-12247039-B2 | Organometallic compound, organic light-emitting device including organometallic compound and electronic apparatus including the organic light-emitting device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-03-11 | — | — | US | disclosed |
| CN-112851638-B | Organometallic compound, organic light-emitting device including the same, and electronic apparatus including the organic light-emitting device | 三星电子株式会社 | 2024-11-15 | — | — | CN | disclosed |
| WO-2024083086-A1 | BICYCLIC DERIVATIVE INTEGRIN INHIBITOR | 上海如凌生物医药有限公司 | 2024-04-25 | — | — | WO | disclosed |
| CN-117903171-A | Integrin inhibitors of a class of bicyclic derivatives | 上海如凌生物医药有限公司 | 2024-04-19 | — | — | CN | disclosed |
| US-11839144-B2 | Tetradentate cyclometalated platinum complexes containing 9,10-dihydroacridine and its analogues | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2023-12-05 | — | — | US | disclosed |
| US-11839144-B2 | Tetradentate cyclometalated platinum complexes containing 9,10-dihydroacridine and its analogues | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2023-12-05 | — | — | US | disclosed |
| US-11839144-B2 | Tetradentate cyclometalated platinum complexes containing 9,10-dihydroacridine and its analogues | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2023-12-05 | — | — | US | disclosed |
| US-20140330019-A1 | Four Coordinated Platinum and Palladium Complexes with Geometrically Distorted Charge Transfer State and Their Applications in Light Emitting Devices | ARIZONA BOARD OF REGENTS ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY | 2014-11-06 | — | — | US | disclosed |
| US-20140330019-A1 | Four Coordinated Platinum and Palladium Complexes with Geometrically Distorted Charge Transfer State and Their Applications in Light Emitting Devices | ARIZONA BOARD OF REGENTS ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY | 2014-11-06 | — | — | US | disclosed |
| US-20140330019-A1 | Four Coordinated Platinum and Palladium Complexes with Geometrically Distorted Charge Transfer State and Their Applications in Light Emitting Devices | ARIZONA BOARD OF REGENTS ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY | 2014-11-06 | — | — | US | disclosed |
| US-8816080-B2 | Four coordinated platinum and palladium complexes with geometrically distorted charge transfer state and their applications in light emitting devices | ARIZONA BOARD OF REGENTS ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2014-08-26 | — | — | US | disclosed |
| US-8816080-B2 | Four coordinated platinum and palladium complexes with geometrically distorted charge transfer state and their applications in light emitting devices | ARIZONA BOARD OF REGENTS ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2014-08-26 | — | — | US | disclosed |
| US-8816080-B2 | Four coordinated platinum and palladium complexes with geometrically distorted charge transfer state and their applications in light emitting devices | ARIZONA BOARD OF REGENTS ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2014-08-26 | — | — | US | disclosed |
| WO-2012112853-A1 | FOUR COORDINATED PLATINUM AND PALLADIUM COMPLEXES WITH GEOMETRICALLY DISTORTED CHARGE TRANSFER STATE AND THEIR APPLICATIONS IN LIGHT EMITTING DEVICES | ARIZONA BOARD OF REGENTS ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2012-08-23 | — | — | WO | disclosed |
| US-20120215001-A1 | FOUR COORDINATED PLATINUM AND PALLADIUM COMPLEXES WITH GEOMETRICALLY DISTORTED CHARGE TRANSFER STATE AND THEIR APPLICATIONS IN LIGHT EMITTING DEVICES | NATIONAL SCIENCE FOUNDATION | 2012-08-23 | — | — | US | disclosed |
| US-20120215001-A1 | FOUR COORDINATED PLATINUM AND PALLADIUM COMPLEXES WITH GEOMETRICALLY DISTORTED CHARGE TRANSFER STATE AND THEIR APPLICATIONS IN LIGHT EMITTING DEVICES | NATIONAL SCIENCE FOUNDATION | 2012-08-23 | — | — | US | disclosed |
| US-20120215001-A1 | FOUR COORDINATED PLATINUM AND PALLADIUM COMPLEXES WITH GEOMETRICALLY DISTORTED CHARGE TRANSFER STATE AND THEIR APPLICATIONS IN LIGHT EMITTING DEVICES | NATIONAL SCIENCE FOUNDATION | 2012-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12247039-B2 | Organometallic compound, organic light-emitting device including organometallic compound and electronic apparatus including the organic light-emitting device | OCIAD1, ORC3, ODC1 | ALDH1A1 23/4885TSHR 3799/4885MAPT 1658/4885 |
| US-12426496-B2 | Organic electroluminescence device and organometallic compound for organic electroluminescence device | SLCO2A1, SLCO4C1, PIEZO1 | ALDH1A1 153/4885TSHR 4395/4885MAPT 1561/4885 |
| US-20260035398-A1 | TETRADENTATE AND OCTAHEDRAL METAL COMPLEXES CONTAINING NAPHTHYRIDINOCARBAZOLE AND ITS ANALOGUES | LBR, SCO2, RAD54L | ALDH1A1 2242/4885TSHR 530/4885MAPT 4844/4885 |
| US-20120215001-A1 | FOUR COORDINATED PLATINUM AND PALLADIUM COMPLEXES WITH GEOMETRICALLY DISTORTED CHARGE TRANSFER STATE AND THEIR APPLICATIONS IN LIGHT EMITTING DEVICES | PDCD4, PDCD1LG2, PDCD1 | ALDH1A1 1858/4885TSHR 3185/4885MAPT 579/4885 |
| US-12312366-B2 | Tetradentate and octahedral metal complexes containing naphthyridinocarbazole and its analogues | PAICS, DNTT, PNPO | ALDH1A1 4508/4885TSHR 2799/4885MAPT 462/4885 |
| US-11839144-B2 | Tetradentate cyclometalated platinum complexes containing 9,10-dihydroacridine and its analogues | DPYD, DCTD, TYMP | ALDH1A1 1020/4885TSHR 2241/4885MAPT 538/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.